Concepedia

Fernando Solimando

FS

Statistics

Publications

2

Citations

54

H-Index

2

Active since

2018

Affiliations

Boehringer Ingelheim (Philippines)(Current)

Asahikawa Medical University

Boehringer Ingelheim (Japan)

Boehringer Ingelheim (Germany)

Fernando Solimando is an author at Boehringer Ingelheim (Philippines).

Publications per year

2018–2018

2

Publications

2

Empagliflozin as add‐on to linagliptin in a fixed‐dose combination in Japanese patients with type 2 diabetes: Glycaemic efficacy and safety profile in a 52‐week, randomized, placebo‐controlled trial

Ryuzo Kawamori, Masakazu Haneda, Keiko Suzaki et al. · Diabetes Obesity and Metabolism · 2018 · 40 citations · Full text

Linagliptin as add‐on to empagliflozin in a fixed‐dose combination in Japanese patients with type 2 diabetes: Glycaemic efficacy and safety profile in a two‐part, randomized, placebo‐controlled trial

Kohei Kaku, Masakazu Haneda, Yuko Tanaka et al. · Diabetes Obesity and Metabolism · 2018 · 14 citations · Full text

1–2 of 2